A Randomized, Double Blind, Parallel, Three Arm, Multicenter, Phase II Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Taxol/Parap
|Effective start/end date||12/1/07 → 6/30/13|
- BRISTOL-MYERS SQUIBB COMPANY
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.